Browsing Tag

fshd

SOLVE FSHD Announces New Collaborative Research Grants to Accelerate Novel Potential…

Eli Pacheco Jul 11, 2023 0

VANCOUVER, British Columbia, July 11, 2023 (GLOBE NEWSWIRE) -- SOLVE FSHD, a venture philanthropy organization catalyzing innovation and removing barriers to accelerate new therapies for…

Health

Epic Bio Presents Compelling Preclinical Data Supporting Clinical Initiation of…

Eli Pacheco Jun 16, 2023 0

- NHP studies demonstrate EPI-321’s favorable safety and pharmacokinetic profile - - IND and CTA applications planned for 2023 - SOUTH SAN FRANCISCO, Calif., June 16, 2023 (GLOBE…

Health

Fulcrum Therapeutics Enrolls First Patient in Pivotal Global Phase 3 Clinical Trial…

Eli Pacheco Jul 5, 2022 0

– REACH is the first Phase 3 trial for this rare, progressive, and debilitating muscular disease –– Losmapimod is an oral small molecule that has the potential to be the first therapy to…

Health

CORRECTION – SOLVE FSHD Supports the FSHD Canada Foundation in Funding of…

Eli Pacheco May 24, 2022 0

VANCOUVER, British Columbia, May 24, 2022 (GLOBE NEWSWIRE) -- In an announcement issued earlier today under the same headline by SOLVE FSHD, please be advised that in the second…

Health

Fulcrum Therapeutics® to Host Virtual Key Opinion Leader Webcast Featuring Losmapimod…

Eli Pacheco Mar 18, 2022 0

Event to discuss unmet need in FSHD, key measures of disease progression and Phase 3 REACH trial Live webcast March 24, 2022 at 10:00am ET CAMBRIDGE, Mass., March 17, 2022 (GLOBE…

Health